OncoSec Medical Incorporated (ONCS): Price and Financial Metrics


OncoSec Medical Incorporated (ONCS): $2.15

-0.01 (-0.46%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ONCS to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

ONCS Stock Price Chart Interactive Chart >

Price chart for ONCS

ONCS Price/Volume Stats

Current price $2.15 52-week high $31.90
Prev. close $2.16 52-week low $1.50
Day low $2.11 Volume 33,500
Day high $2.20 Avg. volume 247,494
50-day MA $2.42 Dividend yield N/A
200-day MA $11.84 Market Cap 6.39M

OncoSec Medical Incorporated (ONCS) Company Bio


OncoSec Medical Inc. provides biomedical services. The Company focuses on commercializing therapeutic oncology products. OncoSec Medical offers patients with alternative treatments to existing therapies to treat cancerous tumors and cancerous cells.


ONCS Latest News Stream


Event/Time News Detail
Loading, please wait...

ONCS Latest Social Stream


Loading social stream, please wait...

View Full ONCS Social Stream

Latest ONCS News From Around the Web

Below are the latest news stories about ONCOSEC MEDICAL INC that investors may wish to consider to help them evaluate ONCS as an investment opportunity.

OncoSec to Present at the RHK Capital Disruptive Growth Conference on December 6, 2022

OncoSec Medical Incorporated (NASDAQ: ONCS) (the "Company" or "OncoSec"), a clinical-stage biotechnology company focused on developing intratumoral immunotherapies to stimulate the patient's own immune system to target and eradicate cancer, today announced that Robert Arch, Ph.D., President and CEO of OncoSec, will be participating at the RHK Capital Disruptive Growth Conference in New York City.

Yahoo | December 5, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about for Wednesday!

William White on InvestorPlace | November 30, 2022

OncoSec Announces Pricing of $3.5 Million Public Offering

OncoSec Medical Incorporated (NASDAQ: ONCS) (the "Company" or "OncoSec"), a clinical-stage biotechnology company focused on developing intratumoral immunotherapies to stimulate the patient's own immune system to target and eradicate cancer, today announced the pricing of its "reasonable best efforts" public offering of 1,166,667 shares of common stock (or common stock equivalents) and Common Warrants to purchase 1,166,667 shares of common stock at a combined price of $3.00 per share, for aggrega

Yahoo | November 30, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Good morning!

William White on InvestorPlace | November 29, 2022

ONCS Stock Alert: What to Know About OncoSec Medical as It Drops Today

Although it usually flies under the radar, ONCS stock is trending today.

David Moadel on InvestorPlace | November 22, 2022

Read More 'ONCS' Stories Here

ONCS Price Returns

1-mo 25.73%
3-mo -77.53%
6-mo -86.43%
1-year -88.53%
3-year -95.28%
5-year -99.51%
YTD 27.98%
2022 -92.04%
2021 -85.12%
2020 256.35%
2019 -71.72%
2018 -60.62%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6574 seconds.